BioSpace News Archive

Femasys Inc. (NASDAQ: FEMY) today announced that it has activated enrollment for its pivotal FemBloc® trial at Stanford Medicine (“Stanford”) in Palo Alto, California.

Zymeworks Inc., a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, announced it is expected to be added to the Nasdaq Biotechnology Index .

Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling devastating diseases, today announced the initiation of dosing in the Phase 2 FORWARD-53 clinical trial, which is evaluating WVE-N531 as a treatment for boys with Duchenne muscular dystrophy (DMD) who are amenable to exon 53 skipping.

CorMedix Inc. (Nasdaq: CRMD) today announced the appointment of Beth Zelnick Kaufman, Esq. as EVP, Chief Legal Officer, and Corporate Secretary, effective December 12, 2023.

Atopic dermatitis (or AD) is a heterogenous, inflammatory condition of the skin and is usually accompanied by itch, redness, and swelling.

Atomic AI, a biotechnology company fusing cutting-edge machine learning with state-of-the-art structural biology to unlock RNA drug discovery, announced that the Company has created the first large language model (LLM) leveraging chemical mapping data.

Long-term use of analgesics such as morphine leads to “tolerance” that reduces drug efficacy. In such cases, dose escalation may be required to achieve the same analgesic effects.

Finacity Corporation announced that it has successfully launched a trade receivables securitization for Laboratorios Sanfer, S.A. de C.V.

Curia, a leading contract research, development and manufacturing organization, announced that Gerald Auer has been appointed as chief financial officer.

Scilex Holding Company, an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, announced a national leading pharmacy chain to stock ELYXYB®.